Back to List View Graph View

Akkermansia muciniphila

Akkermansia muciniphila is a gut-associated bacterium studied for its interactions with host tissues, microbial metabolites, and immune and metabolic pathways.

Where the papers sit

9 papers from the last 6 months study akkermansia muciniphila directly · updated from PubMed 12 Nov 2026

Those 9 are all about one subject.

  • Akkermansia Health Research

    Strain characterization and probiotic testing frame Akkermansia as a candidate for metabolic and disease-modifying interventions. Studies link supplementation or higher tissue abundance to insulin sensitivity, GLP-1 production, obesity, neuroinflammation, cognitive impairment, depression-like behavior and colorectal-cancer immunotherapy. Mechanistic signals include ganglioside-glycan binding, NLRP3 inhibition and altered macrophage efferocytosis, while disease-associated abundance may also promote oxidative stress and breast-cancer risk. The evidence remains preclinical or early clinical and is not yet directionally consistent.

    9 papers

NEW DIRECTION

Mammary-tissue Akkermansia muciniphila is a tumor-promoting, rather than health-promoting, factor in obesity-associated breast cancer

The obesity- and age-associated breast cancer study in postmenopausal women and MMTV-PyMT mice found that elevated mammary-gland A. muciniphila increased oxidative stress, tumorigenesis, and tumor multiplicity, while N-acetylcysteine reduced this effect 42423461Jul. This departs from the set’s otherwise therapeutic or beneficial framing of A. muciniphila by assigning it a tissue-resident, disease-promoting role: in the mammary gland, its elevation may contribute to cancer risk rather than protect against metabolic, inflammatory, or neurological disease.

Papers

The 9 papers from the last 6 months that study akkermansia muciniphila directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Akkermansia Health Research (9)
  1. Genomic and probiotic characterization of newly isolated Akkermansia strains from camel and horse feces in alleviating obesity and metabolic dysregulation. World journal of microbiology & biotechnology · 6 Nov 2026 PMID 42993212
  2. Characterization of a Unique Carbohydrate-Binding Module from Akkermansia muciniphila that Binds Ganglioside-Associated Glycans. Biochemistry · 3 Nov 2026 PMID 42975160
  3. A microbiota-metabolite-glial axis drives white matter repair via isorhamnetin-PSAP-GPR37 signaling after ischemic stroke. Gut microbes · 1 Nov 2026 PMID 42968220
  4. Akkermansia muciniphila attenuates macrophage efferocytosis to enhance anti-PD-1 efficacy in microsatellite-stable colorectal cancer. Cell host & microbe · 16 Oct 2026 PMID 42887494
  5. HtpG-High-Expressing Escherichia coli Promotes Fibrosis in Chronic Pancreatitis. Gastroenterology · 13 Oct 2026 PMID 42869256
  6. Akkermansia muciniphila gavage alleviates depression-like behaviors in female A53T α-synuclein transgenic mice. Behavioural brain research · 7 Aug 2026 PMID 42567327
  7. Obesity and Age Elevate Tissue-Resident Microbiota Akkermansia muciniphila to Induce Oxidative Stress and Promote Breast Cancer Risk. Cancer research · 9 Jul 2026 PMID 42423461
  8. Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome: impact of low baseline gut Akkermansia levels. Gut microbes · 25 Jun 2026 PMID 42343233
  9. Akkermansia muciniphila alleviates diabetic cognitive impairment by inhibiting NLRP3 inflammasome activation and ameliorating hippocampal synaptic defects. Food & function · 16 Jun 2026 PMID 42300325

By study type

Clinical trials (2)
  1. Akkermansia muciniphila attenuates macrophage efferocytosis to enhance anti-PD-1 efficacy in microsatellite-stable colorectal cancer. Cell host & microbe · 16 Oct 2026 PMID 42887494
  2. Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome: impact of low baseline gut Akkermansia levels. Gut microbes · 25 Jun 2026 PMID 42343233
Preclinical: animal, cell and lab studies (6)
  1. Genomic and probiotic characterization of newly isolated Akkermansia strains from camel and horse feces in alleviating obesity and metabolic dysregulation. World journal of microbiology & biotechnology · 6 Nov 2026 PMID 42993212
  2. Characterization of a Unique Carbohydrate-Binding Module from Akkermansia muciniphila that Binds Ganglioside-Associated Glycans. Biochemistry · 3 Nov 2026 PMID 42975160
  3. A microbiota-metabolite-glial axis drives white matter repair via isorhamnetin-PSAP-GPR37 signaling after ischemic stroke. Gut microbes · 1 Nov 2026 PMID 42968220
  4. Akkermansia muciniphila gavage alleviates depression-like behaviors in female A53T α-synuclein transgenic mice. Behavioural brain research · 7 Aug 2026 PMID 42567327
  5. Obesity and Age Elevate Tissue-Resident Microbiota Akkermansia muciniphila to Induce Oxidative Stress and Promote Breast Cancer Risk. Cancer research · 9 Jul 2026 PMID 42423461
  6. Akkermansia muciniphila alleviates diabetic cognitive impairment by inhibiting NLRP3 inflammasome activation and ameliorating hippocampal synaptic defects. Food & function · 16 Jun 2026 PMID 42300325
Unclassified: not yet indexed with MeSH (1)
  1. HtpG-High-Expressing Escherichia coli Promotes Fibrosis in Chronic Pancreatitis. Gastroenterology · 13 Oct 2026 PMID 42869256